AIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
PremiumPress ReleasesAIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
30d ago
Morning Movers: MSG Entertainment rises following quarterly release
Premium
The Fly
Morning Movers: MSG Entertainment rises following quarterly release
1M ago
AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Premium
Press Releases
AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate Update
1M ago
AIM ImmunoTech announces data on Ampligen’s anti-tumor potential
PremiumThe FlyAIM ImmunoTech announces data on Ampligen’s anti-tumor potential
2M ago
AIM ImmunoTech files to sell 11.28M shares of common stock for holders
Premium
The Fly
AIM ImmunoTech files to sell 11.28M shares of common stock for holders
2M ago
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
Premium
Press Releases
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
3M ago
AIM ImmunoTech to Participate in Two Upcoming Investor Conferences
PremiumPress ReleasesAIM ImmunoTech to Participate in Two Upcoming Investor Conferences
4M ago
AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
Premium
Press Releases
AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
4M ago
AIM ImmunoTech reports Q1 EPS (12c) vs (8c) last year
Premium
The Fly
AIM ImmunoTech reports Q1 EPS (12c) vs (8c) last year
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100